Electrocautery ablation of high-grade anal intraepithelial lesions

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs032230341

Enrollment

100

Registered

2023-09-12

Start date

2023-09-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anal intraepithelial neoplasia Anal cancer, Anal intraepithelial neoplasia, HPV

Interventions

Electrocautery ablation therapy using Surgitron dual EMC for anal intraepithelial neoplasia

D000078703

Electrocautery ablation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Subjects who have given written consent to participate in the study. (2) Person aged 18 years or older. (3) Patients with a diagnosis of anal intraepithelial neoplasia based on the results of the pathological finding

Exclusion criteria

Exclusion criteria: (1) Invasive cancer (2) Patients whom the principal investigator judges to be inappropriate for inclusion in the study. (3) pregnant or breastfeeding woman

Design outcomes

Primary

Measure	Time frame
Eradication rate of anal intraepithelial neoplasia at 12 months after the treatment	—

Secondary

Measure	Time frame
Eradication rate of anal intraepithelial neoplasia at each visit after the treatment Adverse effect	—

Contacts

Public ContactNaokatsu Ando

National Center for Global Health and Medicine, Japan Institute for Health Security

ando.n@jihs.go.jp+81-332027181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026